 | |
| President and Chief Medical Officer |
|
| Dr. Vijai Kumar has joined Excel Life Sciences from Neeman Medical International, Inc where he served as the first President and CEO. Prior to that, Dr Kumar worked as Medical Director, Sandoz and Regional Director, Asia for The Upjohn Company, where he was responsible for submitting NDAs for more than 20 drugs. Dr. Kumar has over 31 years experience in Global Drug Development, Strategic Relationship building, Business Development and various other aspects of clinical research and the pharmaceutical industry. He has served as a Member of the expert committee constituted by the Drugs Controller General (India) to develop GCP Guidelines in India and as a member of the Board of Governors for the Institute of Clinical Research, India. Dr Kumar has personally been involved in the conduct of over 200 clinical trials in various therapeutic areas such as, Infectious Disease, Neuropsychiatry, Cardiovascular Disorders, Metabolism and Rheumatology in Asia, Europe and the USA and has presented numerous papers on various aspects of clinical research across the globe. Dr Kumar holds an M.D. in Internal Medicine and an M.B.B.S. from Armed Forces Medical College, Pune. |
|
|
 | |
| Country Head & Director of Operations |
|
| Dr. Das has over 9 years of experience in coordination of all phases of global and domestic clinical trials. Prior to joining Excel Life Sciences, Dr. Das was personally responsible for establishing two major SMOs and one CRO in India. He has led large clinical operations teams and brought many innovations to the field including strategies, systems and processes for faster enrollment and increased retention. Dr. Das' vast experience includes designing and reviewing clinical trial related SOPs and WPDs, designing SOPs for Ethics Committees, budgeting for Clinical Trials and setting up Central Pharmacies. He coordinated the clinical trials at the two sites that successfully passed the first US FDA audit in India. As an active trainer, he worked closely with faculty from Harvard Medical International developing a global training program and has personally trained hundreds of pharma, CRO, SMO, Central Lab and Site employees in ICH-GCP. Dr Das has worked on the faculty of the CDSCO, WHO and ICRI and was also selected as a Task Force Member of CRISP (Clinical Research India / Strategic Program) by FICCI. Dr. Das holds an M.D. in clinical pharmacology from M. K. C. G. Medical College in Orissa, India. |
|
|
 | |
| Sanford |
Pearlman |
| Director of Organizational Development and Effectiveness |
| Sanford has spent the last three years in India where he was most recently the Manager of Training and Reengineering for American Express Global Corporate Services based in Gurgaon. Prior to that, Sanford spent thirteen years in Human Resources where he was responsible for the design, development and implementation of several global corporate wide and business specific initiatives including the revitalization of the American Express culture after 9/11. Sanford is most passionate about personal and organizational effectiveness and brings tremendous experience as a business process and organizational effectiveness consultant. |
|
|
|
